NeuroBo Pharmaceuticals, Inc.(NRBO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NRBO NeuroBo Pharmaceuticals, Inc.

盘后交易 04-24 19:30:18 EDT

3.10

+0.08

+2.65%

盘后3.05

-0.05-1.61%

17:19 EDT

最高3.50	最低2.99	成交量3.94万
今开2.99	昨收3.02	日振幅16.88%
总市值1,521万	流通市值1,461万	总股本490.60万
成交额12.38万	换手率0.83%	流通股本471.39万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"NRBO","market":"US","secType":"STK","nameCN":"NeuroBo Pharmaceuticals, Inc.","latestPrice":3.1,"timestamp":1713988800000,"preClose":3.02,"halted":0,"volume":39359,"hourTrading":{"tag":"盘后","latestPrice":3.05,"preClose":3.1,"latestTime":"17:19 EDT","volume":100,"amount":305,"timestamp":1713993550850},"delay":0,"floatShares":4713905,"shares":4906032,"eps":-2.459999,"marketStatus":"盘后交易","marketStatusCode":4,"change":0.08,"latestTime":"04-24 19:30:18 EDT","open":2.99,"high":3.4999,"low":2.99,"amount":123772.8494927,"amplitude":0.168841,"askPrice":3.49,"askSize":3020,"bidPrice":3,"bidSize":20,"shortable":3,"etf":0,"ttmEps":-2.459999,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1714003200000},"adr":0,"listingDate":1470369600000,"adjPreClose":3.02,"preHourTrading":{"tag":"盘前","latestPrice":3.05,"preClose":3.02,"latestTime":"09:13 EDT","volume":274,"amount":835.6999999999999,"timestamp":1713964411428},"postHourTrading":{"tag":"盘后","latestPrice":3.05,"preClose":3.1,"latestTime":"17:19 EDT","volume":100,"amount":305,"timestamp":1713993550850},"volumeRatio":1.634266},"requestUrl":"/m/hq/s/NRBO","defaultTab":"news","newsList":[{"id":"2429921936","title":"Neurobo Pharmaceuticals, Inc.盘中异动 早盘股价大跌6.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429921936","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429921936?lang=zh_cn&edition=full","pubTime":"2024-04-22 21:39","pubTimestamp":1713793153,"startTime":"0","endTime":"0","summary":"北京时间2024年04月22日21时39分，Neurobo Pharmaceuticals, Inc.股票出现异动，股价大幅下跌6.53%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.43%。其相关个股中，Moolec Science Sa C/Wts 、Moolec Science Sa、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大，Moolec Science Sa、Adial Pharmaceuticals, Inc、亚狮康药业较为活跃，换手率分别为115.91%、46.99%、37.27%，振幅较大的相关个股有Moolec Science Sa C/Wts 、Moolec Science Sa、亚狮康药业，振幅分别为144.06%、30.71%、18.71%。Neurobo Pharmaceuticals, Inc.公司简介：NeuroBo Pharmaceuticals Inc 是一家临床阶段的生物技术公司，主要专注于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042221391479225653&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042221391479225653&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428347438","title":"BUZZ-随着早期肥胖症试验开始给药，NeuroBo Pharma 公司股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2428347438","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2428347438?lang=zh_cn&edition=full","pubTime":"2024-04-17 23:15","pubTimestamp":1713366943,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    4月17日 - ** 药物开发商NeuroBo Pharmaceuticals  股价上涨8.2%至3.68美元 ** 该公司称，它已为其两部分早期研究的第一部分中的第一名患者注射了治疗肥胖症的实验药物 ** 研究的第一部分将招募约 45 名参与者，评估药物的安全性和耐受性** 公司预计在今年第三季度报告第一部分研究的数据** 该药名为DA-1726，每周皮下注射一次，作用于一种名为oxyntomodulin的肠道激素，这种激素通过降低食欲和增加能量消耗来促进减肥。** 包括盘中走势在内，该股今年累计下跌 0.45","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2428345644","title":"Neurobo Pharmaceuticals, Inc.盘中异动 股价大涨8.53%报3.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428345644","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428345644?lang=zh_cn&edition=full","pubTime":"2024-04-17 21:31","pubTimestamp":1713360713,"startTime":"0","endTime":"0","summary":"北京时间2024年04月17日21时31分，Neurobo Pharmaceuticals, Inc.股票出现波动，股价急速上涨8.53%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.67%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Vanda Pharmaceuticals Inc.、Viracta Therapeutics, Inc.涨幅较大，Clearmind Medicine Inc.、Novabay Pharmaceuticals, Inc.、Longeveron Inc.较为活跃，换手率分别为25.43%、21.99%、17.23%，振幅较大的相关个股有Cassava Sciences Inc C/Wts 15/11/2024、Viracta Therapeutics, Inc.、Vanda Pharmaceuticals Inc.，振幅分别为25.29%、15.75%、12.10%。Neurobo Pharmaceuticals, Inc.公司简介：NeuroBo Pharmaceuticals Inc 是一家临床阶段的生物技术公司，主要专注于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417213153878a137b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417213153878a137b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428931804","title":"Neurobo Pharmaceuticals, Inc.盘中异动 大幅下跌5.67%报3.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428931804","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428931804?lang=zh_cn&edition=full","pubTime":"2024-04-17 03:20","pubTimestamp":1713295242,"startTime":"0","endTime":"0","summary":"北京时间2024年04月17日03时20分，Neurobo Pharmaceuticals, Inc.股票出现异动，股价快速跳水5.67%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.36%。其相关个股中，Apollomics Inc C/Wts 01/04/2028 、Jaguar Health, Inc.、Finch Therapeutics Group, Inc.涨幅较大，Palisade Bio, Inc.、Longeveron Inc.、Jaguar Health, Inc.较为活跃，换手率分别为3324.70%、259.57%、206.37%，振幅较大的相关个股有Palisade Bio, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Jaguar Health, Inc.，振幅分别为103.61%、101.94%、97.81%。Neurobo Pharmaceuticals, Inc.公司简介：NeuroBo Pharmaceuticals Inc 是一家临床阶段的生物技术公司，主要专注于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041703204287e81073&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041703204287e81073&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427753032","title":"Neurobo Pharmaceuticals, Inc.盘中异动 股价大涨8.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427753032","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427753032?lang=zh_cn&edition=full","pubTime":"2024-04-13 01:36","pubTimestamp":1712943411,"startTime":"0","endTime":"0","summary":"北京时间2024年04月13日01时36分，Neurobo Pharmaceuticals, Inc.股票出现波动，股价急速上涨8.94%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.47%。其相关个股中，Paxmedica, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Allarity Therapeutics, Inc.、Paxmedica, Inc.、Aptevo Therapeutics Inc.较为活跃，换手率分别为3626.29%、1424.94%、96.01%，振幅较大的相关个股有Paxmedica, Inc.、Allarity Therapeutics, Inc.、180 Life Sciences Corp C/Wts 07/11/2025，振幅分别为93.97%、73.57%、58.59%。Neurobo Pharmaceuticals, Inc.公司简介：NeuroBo Pharmaceuticals Inc 是一家临床阶段的生物技术公司，主要专注于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404130136517a527b3f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404130136517a527b3f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426119145","title":"Neurobo Pharmaceuticals, Inc.盘中异动 股价大跌6.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426119145","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426119145?lang=zh_cn&edition=full","pubTime":"2024-04-09 23:15","pubTimestamp":1712675711,"startTime":"0","endTime":"0","summary":"北京时间2024年04月09日23时15分，Neurobo Pharmaceuticals, Inc.股票出现异动，股价急速跳水6.80%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.32%。其相关个股中，Acrivon Therapeutics, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Vbi Vaccines, Inc.涨幅较大，Mymd Pharmaceuticals, Inc.、Biophytis、Acrivon Therapeutics, Inc.较为活跃，换手率分别为456.14%、104.98%、78.82%，振幅较大的相关个股有Mymd Pharmaceuticals, Inc.、Biophytis、Cadrenal Therapeutics, Inc.，振幅分别为45.14%、40.61%、36.75%。Neurobo Pharmaceuticals, Inc.公司简介：NeuroBo Pharmaceuticals Inc 是一家临床阶段的生物技术公司，主要专注于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404092315127a51a8b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404092315127a51a8b9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421152047","title":"Neurobo Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421152047","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421152047?lang=zh_cn&edition=full","pubTime":"2024-03-21 22:55","pubTimestamp":1711032917,"startTime":"0","endTime":"0","summary":"北京时间2024年03月21日22时55分，Neurobo Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.13%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.83%。Neurobo Pharmaceuticals, Inc.公司简介：NeuroBo Pharmaceuticals Inc 是一家临床阶段的生物技术公司，主要专注于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403212255187a4e43b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403212255187a4e43b6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421787657","title":"Neurobo Pharmaceuticals, Inc.盘中异动 大幅上涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421787657","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421787657?lang=zh_cn&edition=full","pubTime":"2024-03-21 00:48","pubTimestamp":1710953339,"startTime":"0","endTime":"0","summary":"北京时间2024年03月21日00时48分，Neurobo Pharmaceuticals, Inc.股票出现波动，股价大幅拉升5.11%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.91%。其相关个股中，Xtl生物制药、Annovis Bio, Inc.、Brainstorm Cell Therapeutics Inc.涨幅较大，Xtl生物制药、Jaguar Health, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为162.54%、80.21%、43.14%，振幅较大的相关个股有Xtl生物制药、Igc Pharma, Inc.、Brainstorm Cell Therapeutics Inc.，振幅分别为157.69%、40.98%、39.33%。Neurobo Pharmaceuticals, Inc.公司简介：NeuroBo Pharmaceuticals Inc 是一家临床阶段的生物技术公司，主要专注于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240321004859791bc310&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240321004859791bc310&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420003642","title":"Neurobo Pharmaceuticals, Inc.盘中异动 临近收盘大幅下挫5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2420003642","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420003642?lang=zh_cn&edition=full","pubTime":"2024-03-20 04:01","pubTimestamp":1710878469,"startTime":"0","endTime":"0","summary":"北京时间2024年03月20日04时01分，Neurobo Pharmaceuticals, Inc.股票出现异动，股价大幅下跌5.30%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。其相关个股中，Fusion Pharmaceuticals Inc.、Nkgen Biotech Inc C/Wts 31/05/2028、Enliven Therapeutics, Inc.涨幅较大，Enveric Biosciences, Inc.、Hoth Therapeutics, Inc.、Scisparc Ltd.较为活跃，换手率分别为950.74%、447.37%、408.68%，振幅较大的相关个股有Nkgen Biotech Inc C/Wts 31/05/2028、Moolec Science Sa C/Wts 、Artelo Biosciences Inc C/Wts 20/06/2024 ，振幅分别为95.79%、83.33%、75.79%。Neurobo Pharmaceuticals, Inc.公司简介：NeuroBo Pharmaceuticals Inc 是一家临床阶段的生物技术公司，主要专注于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403200401107a4db913&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403200401107a4db913&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419993616","title":"Neurobo Pharmaceuticals, Inc.盘中异动 快速拉升5.37%报4.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419993616","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419993616?lang=zh_cn&edition=full","pubTime":"2024-03-15 02:30","pubTimestamp":1710441029,"startTime":"0","endTime":"0","summary":"北京时间2024年03月15日02时30分，Neurobo Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.37%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.71%。其相关个股中，Revolution Medicines Inc C/Wts 17/12/2026 、Psyence Biomedical Ltd.、知临集团涨幅较大，知临集团、Psyence Biomedical Ltd.、Novabay Pharmaceuticals, Inc.较为活跃，换手率分别为804.37%、209.92%、181.87%，振幅较大的相关个股有Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Psyence Biomedical Ltd.、知临集团，振幅分别为110.40%、87.49%、76.91%。Neurobo Pharmaceuticals, Inc.公司简介：NeuroBo Pharmaceuticals Inc 是一家临床阶段的生物技术公司，主要专注于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403150230297a4cc0b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403150230297a4cc0b0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419805736","title":"Neurobo Pharmaceuticals, Inc.盘中异动 早盘大幅跳水6.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419805736","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419805736?lang=zh_cn&edition=full","pubTime":"2024-03-13 21:45","pubTimestamp":1710337500,"startTime":"0","endTime":"0","summary":"北京时间2024年03月13日21时45分，Neurobo Pharmaceuticals, Inc.股票出现异动，股价大幅跳水6.98%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。其相关个股中，Estrella Immunopharma Inc C/Wts 29/09/2028、Nucana Plc、Kintara Therapeutics, Inc.涨幅较大，Kintara Therapeutics, Inc.、Nucana Plc、Revelation Biosciences, Inc.较为活跃，换手率分别为142.32%、49.62%、30.17%，振幅较大的相关个股有Nucana Plc、Kintara Therapeutics, Inc.、Psyence Biomedical Ltd.，振幅分别为39.47%、29.55%、17.89%。Neurobo Pharmaceuticals, Inc.公司简介：NeuroBo Pharmaceuticals Inc 是一家临床阶段的生物技术公司，主要专注于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240313214501861dddd9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240313214501861dddd9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419852296","title":"BUZZ-NeuroBo Pharma 在安全性审查结果表明 MASH 药物研究可以继续后股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2419852296","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2419852296?lang=zh_cn&edition=full","pubTime":"2024-03-13 20:40","pubTimestamp":1710333656,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    3月13日 - ** 药物开发商NeuroBo Pharmaceuticals   股价盘前上涨8%至5.26美元** NRBO称 (link)，一个安全审查委员会建议公司的实验性MASH药物的中期试验可以继续进行，无需修改。** 首席执行官 Hyung Heon Kim 表示：\"该建议是该药物 DA-1241 安全性的早期迹象。** 代谢功能障碍相关性脂肪性肝炎(MASH) 是一种脂肪肝，约占美国人口的 5%。** 截至上次收盘，股价累计上涨 31.7","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2419550102","title":"Neurobo Pharmaceuticals, Inc.盘中异动 股价大跌6.25%报4.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419550102","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419550102?lang=zh_cn&edition=full","pubTime":"2024-03-13 00:53","pubTimestamp":1710262410,"startTime":"0","endTime":"0","summary":"北京时间2024年03月13日00时53分，Neurobo Pharmaceuticals, Inc.股票出现波动，股价快速下挫6.25%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.61%。其相关个股中，Regulus Therapeutics Inc.、Artelo Biosciences Inc C/Wts 20/06/2024 、Dermata Therapeutics Inc C/Wts 涨幅较大，Regulus Therapeutics Inc.、Tc Biopharm  Plc、Scisparc Ltd.较为活跃，换手率分别为681.69%、311.96%、164.52%，振幅较大的相关个股有Regulus Therapeutics Inc.、Artelo Biosciences Inc C/Wts 20/06/2024 、Celularity Inc C/Wts 16/07/2026 ，振幅分别为131.16%、74.77%、66.13%。Neurobo Pharmaceuticals, Inc.公司简介：NeuroBo Pharmaceuticals Inc 是一家临床阶段的生物技术公司，主要专注于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031300533087e783e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031300533087e783e3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417290036","title":"Neurobo Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2417290036","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417290036?lang=zh_cn&edition=full","pubTime":"2024-03-06 23:02","pubTimestamp":1709737320,"startTime":"0","endTime":"0","summary":"北京时间2024年03月06日23时02分，Neurobo Pharmaceuticals, Inc.股票出现波动，股价急速跳水5.41%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.03%。其相关个股中，Biomx Inc.、知临集团、Nkgen Biotech, Inc.涨幅较大，知临集团、Creative Medical Technology Holdings, Inc.、Biomx Inc.较为活跃，换手率分别为181.43%、177.68%、173.83%，振幅较大的相关个股有Biomx Inc.、知临集团、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为93.03%、74.26%、70.90%。Neurobo Pharmaceuticals, Inc.公司简介：NeuroBo Pharmaceuticals Inc 是一家临床阶段的生物技术公司，主要专注于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240306230200861dbd7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240306230200861dbd7d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416879123","title":"Neurobo Pharmaceuticals, Inc.盘中异动 大幅拉升5.12%报6.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2416879123","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416879123?lang=zh_cn&edition=full","pubTime":"2024-03-04 23:20","pubTimestamp":1709565621,"startTime":"0","endTime":"0","summary":"北京时间2024年03月04日23时20分，Neurobo Pharmaceuticals, Inc.股票出现异动，股价快速上涨5.12%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。其相关个股中，Quoin Pharmaceuticals Ltd、Tc Biopharm  Plc C/Wts 10/02/2028 、Jaguar Health, Inc.涨幅较大，Quoin Pharmaceuticals Ltd、Jaguar Health, Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为2016.71%、262.05%、116.81%，振幅较大的相关个股有Ys Biopharma Co Ltd C/Wts 15/03/2028 、Quoin Pharmaceuticals Ltd、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为79.15%、68.95%、63.71%。Neurobo Pharmaceuticals, Inc.公司简介：NeuroBo Pharmaceuticals Inc 是一家临床阶段的生物技术公司，主要专注于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403042320217a495368&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403042320217a495368&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416647306","title":"Neurobo Pharmaceuticals, Inc.盘中异动 急速上涨5.18%报6.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2416647306","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416647306?lang=zh_cn&edition=full","pubTime":"2024-03-01 23:10","pubTimestamp":1709305805,"startTime":"0","endTime":"0","summary":"北京时间2024年03月01日23时10分，Neurobo Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.18%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.62%。其相关个股中，Biovie Inc.、Adial Pharmaceuticals, Inc、Carmell Corp C/Wts 12/07/2028 涨幅较大，Adial Pharmaceuticals, Inc、Enveric Biosciences, Inc.、Biovie Inc.较为活跃，换手率分别为2800.28%、286.31%、121.84%，振幅较大的相关个股有Pasithea Therapeutics Corp C/Wts 12/08/2026 、Carmell Corp C/Wts 12/07/2028 、Biovie Inc.，振幅分别为81.48%、71.25%、69.35%。Neurobo Pharmaceuticals, Inc.公司简介：NeuroBo Pharmaceuticals Inc 是一家临床阶段的生物技术公司，主要专注于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403012310057a489768&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403012310057a489768&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.neurobopharma.com","stockEarnings":[{"period":"1week","weight":-0.1118},{"period":"1month","weight":-0.3229},{"period":"3month","weight":-0.0163},{"period":"6month","weight":-0.1401},{"period":"1year","weight":-0.4519},{"period":"ytd","weight":-0.183}],"compareEarnings":[{"period":"1week","weight":0.0042},{"period":"1month","weight":-0.0299},{"period":"3month","weight":0.0417},{"period":"6month","weight":0.2257},{"period":"1year","weight":0.2254},{"period":"ytd","weight":0.0638}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"NeuroBo Pharmaceuticals, Inc.于2008年11月10日在密歇根以Michigan Life Therapeutics, LLC (MLT)这个名字注册成立。NeuroBo Pharmaceuticals, Inc.是一家临床阶段的生物技术公司，主要致力于开发和商业化治疗心脏代谢疾病的新药物。NeuroBo有两个主要项目，重点治疗非酒精性脂肪性肝炎（NASH）、肥胖症和2型糖尿病（T2D）。","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.101843},{"month":2,"riseRate":0.375,"avgChangeRate":0.080599},{"month":3,"riseRate":0.5,"avgChangeRate":-0.020088},{"month":4,"riseRate":0.375,"avgChangeRate":-0.105672},{"month":5,"riseRate":0.142857,"avgChangeRate":-0.144335},{"month":6,"riseRate":0.571429,"avgChangeRate":0.079355},{"month":7,"riseRate":0.285714,"avgChangeRate":-0.00289},{"month":8,"riseRate":0.142857,"avgChangeRate":-0.23779},{"month":9,"riseRate":0.375,"avgChangeRate":0.039055},{"month":10,"riseRate":0.125,"avgChangeRate":-0.215957},{"month":11,"riseRate":0.375,"avgChangeRate":-0.112459},{"month":12,"riseRate":0.125,"avgChangeRate":-0.172588}],"exchange":"NASDAQ","name":"NeuroBo Pharmaceuticals, Inc.","nameEN":"NeuroBo Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"NeuroBo Pharmaceuticals, Inc.(NRBO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供NeuroBo Pharmaceuticals, Inc.(NRBO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"NeuroBo Pharmaceuticals, Inc.,NRBO,NeuroBo Pharmaceuticals, Inc.股票,NeuroBo Pharmaceuticals, Inc.股票老虎,NeuroBo Pharmaceuticals, Inc.股票老虎国际,NeuroBo Pharmaceuticals, Inc.行情,NeuroBo Pharmaceuticals, Inc.股票行情,NeuroBo Pharmaceuticals, Inc.股价,NeuroBo Pharmaceuticals, Inc.股市,NeuroBo Pharmaceuticals, Inc.股票价格,NeuroBo Pharmaceuticals, Inc.股票交易,NeuroBo Pharmaceuticals, Inc.股票购买,NeuroBo Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"NeuroBo Pharmaceuticals, Inc.(NRBO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供NeuroBo Pharmaceuticals, Inc.(NRBO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}